Long-term safety and efficacy of garadacimab for preventing hereditary angioedema attacks: Phase 3 open-label extension study. Reshef A, Hsu C, Katelaris CH, Li PH, et al. Allergy 2025;80:545-556.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Reshef A, Hsu C, Katelaris CH, Li PH, et al. Long-term safety and efficacy of garadacimab for preventing hereditary angioedema attacks: Phase 3 open-label extension study. Allergy 2025;80:545-556.
PMID: 39370961